Fagron NV (EBR:FAGR)
23.85
+0.10 (0.42%)
Apr 29, 2026, 2:44 PM CET
Fagron NV Revenue
In the year 2025, Fagron NV had annual revenue of 952.17M EUR with 9.20% growth. Fagron NV had revenue of 476.04M in the half year ending December 31, 2025, with 21.62% growth.
Revenue
952.17M
Revenue Growth
+9.20%
P/S Ratio
1.83
Revenue / Employee
227.09K
Employees
4,193
Market Cap
1.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 952.17M | 80.21M | 9.20% |
| Dec 31, 2024 | 871.96M | 108.97M | 14.28% |
| Dec 31, 2023 | 762.99M | 79.11M | 11.57% |
| Dec 31, 2022 | 683.88M | 110.07M | 19.18% |
| Dec 31, 2021 | 573.81M | 17.84M | 3.21% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 7.74B |
| argenx SE | 3.61B |
| Financière de Tubize | 13.26K |
| Ion Beam Applications | 620.20M |
| Onward Medical | 5.41M |
| Hyloris Pharmaceuticals | 8.83M |
| Nyxoah | 10.02M |
| Sequana Medical NV | 105.50K |
Fagron NV News
- 13 days ago - Pete Pharma and Fagron Enter Strategic Distribution Partnership to Expand Access to Pharmaceutical 3D Printing Across North America - Business Wire
- 19 days ago - Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026 - GlobeNewsWire
- 20 days ago - Fagron NV Earnings Call Transcript: Q1 2026 - Transcripts
- 20 days ago - Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth - GlobeNewsWire
- 4 weeks ago - Fagron increases share capital through exercise subscription rights - GlobeNewsWire
- 2 months ago - Full Year 2025 Fagron NV Earnings Call Transcript - GuruFocus
- 2 months ago - Fagron NV Earnings Call Transcript: H2 2025 - Transcripts
- 5 months ago - Pharma 5.0 delivers personalized treatment using AI, says Fagron CEO - CNBC